For stacking with Tirzepatide, most protocols use the no-DAC version because it creates more physiological pulsatile GH release patterns
Injections are all we do
The moment you have finished drawing the required amount from the vial, it goes directly back into the refrigerator
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
By purchasing, the buyer affirms they are a qualified researcher and accepts full responsibility for safe handling, storage, and disposal in accordance with applicable laws and institutional policies
Free, uncomplexed GHK and excess copper salts can also appear
